280. Huge arteriovenous malformation with cervicofacial or limb lesion Clinical trials / Disease details
Clinical trials : 25 / Drugs : 29 - (DrugBank : 15) / Drug target genes : 14 - Drug target pathways : 153
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03076099 (ClinicalTrials.gov) | January 1, 2016 | 6/3/2017 | Dexmedetomidine on Post-operative Blood Pressure in Bain Arteriovenous Malformation Embolization | Effects of Dexmedetomidine on Post-operative Blood Pressure in Patients Undergoing Brain Arteriovenous Malformation Embolization | Anesthesia | Drug: Dexmedetomidine;Other: normal saline | Nan Jiang | NULL | Recruiting | 18 Years | 65 Years | All | 30 | N/A | China |
| 2 | NCT02552459 (ClinicalTrials.gov) | September 2015 | 26/5/2015 | Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in Neurosurgery | Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in Neurosurgery: A Randomized Controlled Study | Arteriovenous Malformation | Drug: Sufentanil;Drug: dexmedetomidine 1;Drug: dexmedetomidine 2;Drug: dexmedetomidine 3 | First Affiliated Hospital, Sun Yat-Sen University | NULL | Recruiting | 18 Years | 65 Years | Both | 120 | Phase 4 | China |